The Icelandic Medicines Agency will be closed 24, 25 and 31 December 2015 and January 1 2016.

The Icelandic Medicines Agency has updated the application form for classification.

From Thursday the 15^th of October until Tuesday the 20^th of October The Icelandic Medicines Agency is closed. The Agency will reopen Wednesday 21^st of October.

Deadline for submitting a clinical trial application (CTA) in 2015 is 11 December.

The Icelandic Medicines Agency will be closed Friday 25 September, due to an annual Out-of-office Workshop by staff.

Referral Art. 31, EMEA/H/A-31/1400 regarding Hydroxyzine hydrochloride/Atarax is finished

.

Due to summer holiday the Icelandic Medicines Agency (IMA) will not confirm receipt of clinical trial applications from 15 June to 15 August 2015.

An electronic signature leads to more effective resolution of errands, less use of paper and postal cost.

Rúna Hauksdóttir is the new Executive Director of IMA as from 1 February 2015.

Referral Art. 30, EMEA/H/A-30/1375 regarding  Nasonex and associated names was finalised 20 January 2015.

Referral Art. 31, EMEA/H/A-31/1383 regarding Colistimethate Alvogen 1 milljón a.e. og 2 milljónir a.e. stungulyfs-/innrennslisstofn, lausn was finalised 17 December 2014.